IGMS — IGM Biosciences Share News
0.000.00%
Last trade - 00:00- $76.57m
- -$27.73m
- $2.68m
IGM Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: IGM Announces Proposed Public Offering
IGM Biosciences up on collaboration with Sanofi
Brief: IGM Biosciences Announces Q4 Results
Sanofi slips after Dupixent peak sales target misses expectations
Sanofi targets Dupixent peak sales of over 13 bln euros (updated)
Brief: Sanofi and IGM Biosciences to collaborate in the sphere of oncology, IGM to receive $150 million upfront payments
IGM Biosciences Inc expected to post a loss of $1.54 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Avanos Medical, Kraft Heinz, NetApp
U.S. STOCKS ON THE MOVE-Arena Pharma, Harley-Davidson, U.S. banks, travel stocks
U.S. STOCKS ON THE MOVE-Novavax, Harley-Davidson, Peloton, Arena Pharma
U.S. RESEARCH ROUNDUP- Braze, Coca-Cola, Sweetgreen
Brief: IGM Biosciences To Collaborate On The Study Of IGM And IGA Antibodies For Prevention Of Malaria
IGM Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: IGM Biosciences Announces Q3 2021 Financial Results And Provides Corporate Update
IGM Biosciences Inc expected to post a loss of $1.37 a share - Earnings Preview
Brief: IGM Biosciences Appoints Leaders, Forms Two Business Units
U.S. RESEARCH ROUNDUP-Adobe, Goodrx Holdings, PG&E
IGM Biosciences Inc reports results for the quarter ended in June - Earnings Summary